世界の小児呼吸器疾患治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Pediatric Respiratory Disease Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4675 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、小児呼吸器疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗炎症薬、気管支拡張薬、併用薬、コルチコステロイド、モノクローナル抗体、その他）、用途別市場規模（喘息、嚢胞性線維症、細気管支炎、肺炎、特発性肺線維症、結核、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・小児呼吸器疾患治療薬の市場動向 ・企業の競争状況、市場シェア ・小児呼吸器疾患治療薬の種類別市場規模と予測2016-2027（抗炎症薬、気管支拡張薬、併用薬、コルチコステロイド、モノクローナル抗体、その他） ・小児呼吸器疾患治療薬の用途別市場規模と予測2016-2027（喘息、嚢胞性線維症、細気管支炎、肺炎、特発性肺線維症、結核、その他） ・小児呼吸器疾患治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・小児呼吸器疾患治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・小児呼吸器疾患治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・小児呼吸器疾患治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・小児呼吸器疾患治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Novartis AG、Bayer AG、GSK、Merck、Boehringer Ingelheim、Regeneron Pharmaceuticals、AstraZeneca、Roche） ・結論

Market Analysis and Insights: Global Pediatric Respiratory Disease Therapeutics Market
The global Pediatric Respiratory Disease Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pediatric Respiratory Disease Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pediatric Respiratory Disease Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pediatric Respiratory Disease Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pediatric Respiratory Disease Therapeutics market.

Global Pediatric Respiratory Disease Therapeutics Scope and Market Size
Pediatric Respiratory Disease Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pediatric Respiratory Disease Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Anti-Inflammatory Drugs
Bronchodilators
Combination Drugs
Corticosteroid
Monoclonal Antibodies
Others

Segment by Application
Asthma
Cystic Fibrosis
Bronchiolitis
Pneumonia
Idiopathic Pulmonary Fibrosis
Tuberculosis
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novartis AG
Bayer AG
GSK
Merck
Boehringer Ingelheim
Regeneron Pharmaceuticals
AstraZeneca
Roche

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatric Respiratory Disease Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Anti-Inflammatory Drugs
1.2.3 Bronchodilators
1.2.4 Combination Drugs
1.2.5 Corticosteroid
1.2.6 Monoclonal Antibodies
1.2.7 Others
1.3 Market by Application
1.3.1 Global Pediatric Respiratory Disease Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Asthma
1.3.3 Cystic Fibrosis
1.3.4 Bronchiolitis
1.3.5 Pneumonia
1.3.6 Idiopathic Pulmonary Fibrosis
1.3.7 Tuberculosis
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Pediatric Respiratory Disease Therapeutics Market Perspective (2016-2027)
2.2 Pediatric Respiratory Disease Therapeutics Growth Trends by Regions
2.2.1 Pediatric Respiratory Disease Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pediatric Respiratory Disease Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Pediatric Respiratory Disease Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Pediatric Respiratory Disease Therapeutics Industry Dynamic
2.3.1 Pediatric Respiratory Disease Therapeutics Market Trends
2.3.2 Pediatric Respiratory Disease Therapeutics Market Drivers
2.3.3 Pediatric Respiratory Disease Therapeutics Market Challenges
2.3.4 Pediatric Respiratory Disease Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Pediatric Respiratory Disease Therapeutics Players by Revenue
3.1.1 Global Top Pediatric Respiratory Disease Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Pediatric Respiratory Disease Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Pediatric Respiratory Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pediatric Respiratory Disease Therapeutics Revenue
3.4 Global Pediatric Respiratory Disease Therapeutics Market Concentration Ratio
3.4.1 Global Pediatric Respiratory Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatric Respiratory Disease Therapeutics Revenue in 2020
3.5 Pediatric Respiratory Disease Therapeutics Key Players Head office and Area Served
3.6 Key Players Pediatric Respiratory Disease Therapeutics Product Solution and Service
3.7 Date of Enter into Pediatric Respiratory Disease Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Pediatric Respiratory Disease Therapeutics Breakdown Data by Type
4.1 Global Pediatric Respiratory Disease Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Pediatric Respiratory Disease Therapeutics Forecasted Market Size by Type (2022-2027)

5 Pediatric Respiratory Disease Therapeutics Breakdown Data by Application
5.1 Global Pediatric Respiratory Disease Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Pediatric Respiratory Disease Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Pediatric Respiratory Disease Therapeutics Market Size (2016-2027)
6.2 North America Pediatric Respiratory Disease Therapeutics Market Size by Type
6.2.1 North America Pediatric Respiratory Disease Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Pediatric Respiratory Disease Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Pediatric Respiratory Disease Therapeutics Market Size by Type (2016-2027)
6.3 North America Pediatric Respiratory Disease Therapeutics Market Size by Application
6.3.1 North America Pediatric Respiratory Disease Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Pediatric Respiratory Disease Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Pediatric Respiratory Disease Therapeutics Market Size by Application (2016-2027)
6.4 North America Pediatric Respiratory Disease Therapeutics Market Size by Country
6.4.1 North America Pediatric Respiratory Disease Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Pediatric Respiratory Disease Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Pediatric Respiratory Disease Therapeutics Market Size (2016-2027)
7.2 Europe Pediatric Respiratory Disease Therapeutics Market Size by Type
7.2.1 Europe Pediatric Respiratory Disease Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Pediatric Respiratory Disease Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Pediatric Respiratory Disease Therapeutics Market Size by Type (2016-2027)
7.3 Europe Pediatric Respiratory Disease Therapeutics Market Size by Application
7.3.1 Europe Pediatric Respiratory Disease Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Pediatric Respiratory Disease Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Pediatric Respiratory Disease Therapeutics Market Size by Application (2016-2027)
7.4 Europe Pediatric Respiratory Disease Therapeutics Market Size by Country
7.4.1 Europe Pediatric Respiratory Disease Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Pediatric Respiratory Disease Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size by Type
8.2.1 Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size by Application
8.3.1 Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size by Region
8.4.1 Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Pediatric Respiratory Disease Therapeutics Market Size (2016-2027)
9.2 Latin America Pediatric Respiratory Disease Therapeutics Market Size by Type
9.2.1 Latin America Pediatric Respiratory Disease Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Pediatric Respiratory Disease Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Pediatric Respiratory Disease Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Pediatric Respiratory Disease Therapeutics Market Size by Application
9.3.1 Latin America Pediatric Respiratory Disease Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Pediatric Respiratory Disease Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Pediatric Respiratory Disease Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Pediatric Respiratory Disease Therapeutics Market Size by Country
9.4.1 Latin America Pediatric Respiratory Disease Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Pediatric Respiratory Disease Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size by Type
10.2.1 Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size by Application
10.3.1 Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size by Country
10.4.1 Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Pediatric Respiratory Disease Therapeutics Introduction
11.1.4 Novartis AG Revenue in Pediatric Respiratory Disease Therapeutics Business (2016-2021)
11.1.5 Novartis AG Recent Development
11.2 Bayer AG
11.2.1 Bayer AG Company Details
11.2.2 Bayer AG Business Overview
11.2.3 Bayer AG Pediatric Respiratory Disease Therapeutics Introduction
11.2.4 Bayer AG Revenue in Pediatric Respiratory Disease Therapeutics Business (2016-2021)
11.2.5 Bayer AG Recent Development
11.3 GSK
11.3.1 GSK Company Details
11.3.2 GSK Business Overview
11.3.3 GSK Pediatric Respiratory Disease Therapeutics Introduction
11.3.4 GSK Revenue in Pediatric Respiratory Disease Therapeutics Business (2016-2021)
11.3.5 GSK Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Pediatric Respiratory Disease Therapeutics Introduction
11.4.4 Merck Revenue in Pediatric Respiratory Disease Therapeutics Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Pediatric Respiratory Disease Therapeutics Introduction
11.5.4 Boehringer Ingelheim Revenue in Pediatric Respiratory Disease Therapeutics Business (2016-2021)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Regeneron Pharmaceuticals
11.6.1 Regeneron Pharmaceuticals Company Details
11.6.2 Regeneron Pharmaceuticals Business Overview
11.6.3 Regeneron Pharmaceuticals Pediatric Respiratory Disease Therapeutics Introduction
11.6.4 Regeneron Pharmaceuticals Revenue in Pediatric Respiratory Disease Therapeutics Business (2016-2021)
11.6.5 Regeneron Pharmaceuticals Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Pediatric Respiratory Disease Therapeutics Introduction
11.7.4 AstraZeneca Revenue in Pediatric Respiratory Disease Therapeutics Business (2016-2021)
11.7.5 AstraZeneca Recent Development
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Roche Business Overview
11.8.3 Roche Pediatric Respiratory Disease Therapeutics Introduction
11.8.4 Roche Revenue in Pediatric Respiratory Disease Therapeutics Business (2016-2021)
11.8.5 Roche Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Pediatric Respiratory Disease Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Anti-Inflammatory Drugs
Table 3. Key Players of Bronchodilators
Table 4. Key Players of Combination Drugs
Table 5. Key Players of Corticosteroid
Table 6. Key Players of Monoclonal Antibodies
Table 7. Key Players of Others
Table 8. Global Pediatric Respiratory Disease Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Pediatric Respiratory Disease Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Pediatric Respiratory Disease Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Pediatric Respiratory Disease Therapeutics Market Share by Regions (2016-2021)
Table 12. Global Pediatric Respiratory Disease Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Pediatric Respiratory Disease Therapeutics Market Share by Regions (2022-2027)
Table 14. Pediatric Respiratory Disease Therapeutics Market Trends
Table 15. Pediatric Respiratory Disease Therapeutics Market Drivers
Table 16. Pediatric Respiratory Disease Therapeutics Market Challenges
Table 17. Pediatric Respiratory Disease Therapeutics Market Restraints
Table 18. Global Pediatric Respiratory Disease Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Pediatric Respiratory Disease Therapeutics Market Share by Players (2016-2021)
Table 20. Global Top Pediatric Respiratory Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatric Respiratory Disease Therapeutics as of 2020)
Table 21. Ranking of Global Top Pediatric Respiratory Disease Therapeutics Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Pediatric Respiratory Disease Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Pediatric Respiratory Disease Therapeutics Product Solution and Service
Table 25. Date of Enter into Pediatric Respiratory Disease Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Pediatric Respiratory Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Pediatric Respiratory Disease Therapeutics Revenue Market Share by Type (2016-2021)
Table 29. Global Pediatric Respiratory Disease Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Pediatric Respiratory Disease Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Pediatric Respiratory Disease Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Pediatric Respiratory Disease Therapeutics Revenue Market Share by Application (2016-2021)
Table 33. Global Pediatric Respiratory Disease Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Pediatric Respiratory Disease Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Pediatric Respiratory Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Pediatric Respiratory Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Pediatric Respiratory Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Pediatric Respiratory Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Pediatric Respiratory Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Pediatric Respiratory Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Pediatric Respiratory Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Pediatric Respiratory Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Pediatric Respiratory Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Pediatric Respiratory Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Pediatric Respiratory Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Pediatric Respiratory Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Pediatric Respiratory Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Pediatric Respiratory Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Pediatric Respiratory Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Pediatric Respiratory Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Pediatric Respiratory Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Pediatric Respiratory Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 65. Novartis AG Company Details
Table 66. Novartis AG Business Overview
Table 67. Novartis AG Pediatric Respiratory Disease Therapeutics Product
Table 68. Novartis AG Revenue in Pediatric Respiratory Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 69. Novartis AG Recent Development
Table 70. Bayer AG Company Details
Table 71. Bayer AG Business Overview
Table 72. Bayer AG Pediatric Respiratory Disease Therapeutics Product
Table 73. Bayer AG Revenue in Pediatric Respiratory Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 74. Bayer AG Recent Development
Table 75. GSK Company Details
Table 76. GSK Business Overview
Table 77. GSK Pediatric Respiratory Disease Therapeutics Product
Table 78. GSK Revenue in Pediatric Respiratory Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 79. GSK Recent Development
Table 80. Merck Company Details
Table 81. Merck Business Overview
Table 82. Merck Pediatric Respiratory Disease Therapeutics Product
Table 83. Merck Revenue in Pediatric Respiratory Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 84. Merck Recent Development
Table 85. Boehringer Ingelheim Company Details
Table 86. Boehringer Ingelheim Business Overview
Table 87. Boehringer Ingelheim Pediatric Respiratory Disease Therapeutics Product
Table 88. Boehringer Ingelheim Revenue in Pediatric Respiratory Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 89. Boehringer Ingelheim Recent Development
Table 90. Regeneron Pharmaceuticals Company Details
Table 91. Regeneron Pharmaceuticals Business Overview
Table 92. Regeneron Pharmaceuticals Pediatric Respiratory Disease Therapeutics Product
Table 93. Regeneron Pharmaceuticals Revenue in Pediatric Respiratory Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 94. Regeneron Pharmaceuticals Recent Development
Table 95. AstraZeneca Company Details
Table 96. AstraZeneca Business Overview
Table 97. AstraZeneca Pediatric Respiratory Disease Therapeutics Product
Table 98. AstraZeneca Revenue in Pediatric Respiratory Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 99. AstraZeneca Recent Development
Table 100. Roche Company Details
Table 101. Roche Business Overview
Table 102. Roche Revenue in Pediatric Respiratory Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 103. Roche Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pediatric Respiratory Disease Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Anti-Inflammatory Drugs Features
Figure 3. Bronchodilators Features
Figure 4. Combination Drugs Features
Figure 5. Corticosteroid Features
Figure 6. Monoclonal Antibodies Features
Figure 7. Others Features
Figure 8. Global Pediatric Respiratory Disease Therapeutics Market Share by Application: 2020 VS 2027
Figure 9. Asthma Case Studies
Figure 10. Cystic Fibrosis Case Studies
Figure 11. Bronchiolitis Case Studies
Figure 12. Pneumonia Case Studies
Figure 13. Idiopathic Pulmonary Fibrosis Case Studies
Figure 14. Tuberculosis Case Studies
Figure 15. Others Case Studies
Figure 16. Pediatric Respiratory Disease Therapeutics Report Years Considered
Figure 17. Global Pediatric Respiratory Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 18. Global Pediatric Respiratory Disease Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 19. Global Pediatric Respiratory Disease Therapeutics Market Share by Regions: 2020 VS 2027
Figure 20. Global Pediatric Respiratory Disease Therapeutics Market Share by Regions (2022-2027)
Figure 21. Global Pediatric Respiratory Disease Therapeutics Market Share by Players in 2020
Figure 22. Global Top Pediatric Respiratory Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatric Respiratory Disease Therapeutics as of 2020
Figure 23. The Top 10 and 5 Players Market Share by Pediatric Respiratory Disease Therapeutics Revenue in 2020
Figure 24. Global Pediatric Respiratory Disease Therapeutics Revenue Market Share by Type (2016-2021)
Figure 25. Global Pediatric Respiratory Disease Therapeutics Revenue Market Share by Type (2022-2027)
Figure 26. North America Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. North America Pediatric Respiratory Disease Therapeutics Market Share by Type (2016-2027)
Figure 28. North America Pediatric Respiratory Disease Therapeutics Market Share by Application (2016-2027)
Figure 29. North America Pediatric Respiratory Disease Therapeutics Market Share by Country (2016-2027)
Figure 30. United States Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Canada Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Europe Pediatric Respiratory Disease Therapeutics Market Share by Type (2016-2027)
Figure 34. Europe Pediatric Respiratory Disease Therapeutics Market Share by Application (2016-2027)
Figure 35. Europe Pediatric Respiratory Disease Therapeutics Market Share by Country (2016-2027)
Figure 36. Germany Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. France Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. U.K. Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Italy Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Russia Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Nordic Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Share by Type (2016-2027)
Figure 44. Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Share by Application (2016-2027)
Figure 45. Asia-Pacific Pediatric Respiratory Disease Therapeutics Market Share by Region (2016-2027)
Figure 46. China Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Japan Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. South Korea Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Southeast Asia Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. India Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Australia Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Latin America Pediatric Respiratory Disease Therapeutics Market Share by Type (2016-2027)
Figure 54. Latin America Pediatric Respiratory Disease Therapeutics Market Share by Application (2016-2027)
Figure 55. Latin America Pediatric Respiratory Disease Therapeutics Market Share by Country (2016-2027)
Figure 56. Mexico Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Brazil Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Share by Type (2016-2027)
Figure 60. Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Share by Application (2016-2027)
Figure 61. Middle East & Africa Pediatric Respiratory Disease Therapeutics Market Share by Country (2016-2027)
Figure 62. Turkey Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Saudi Arabia Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. UAE Pediatric Respiratory Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 65. Novartis AG Revenue Growth Rate in Pediatric Respiratory Disease Therapeutics Business (2016-2021)
Figure 66. Bayer AG Revenue Growth Rate in Pediatric Respiratory Disease Therapeutics Business (2016-2021)
Figure 67. GSK Revenue Growth Rate in Pediatric Respiratory Disease Therapeutics Business (2016-2021)
Figure 68. Merck Revenue Growth Rate in Pediatric Respiratory Disease Therapeutics Business (2016-2021)
Figure 69. Boehringer Ingelheim Revenue Growth Rate in Pediatric Respiratory Disease Therapeutics Business (2016-2021)
Figure 70. Regeneron Pharmaceuticals Revenue Growth Rate in Pediatric Respiratory Disease Therapeutics Business (2016-2021)
Figure 71. AstraZeneca Revenue Growth Rate in Pediatric Respiratory Disease Therapeutics Business (2016-2021)
Figure 72. Roche Revenue Growth Rate in Pediatric Respiratory Disease Therapeutics Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

---